TokenPost topic

Lineage Cell Therapeutics

1 TokenPost story is tagged Lineage Cell Therapeutics. The newest appear first.

Latest Lineage Cell Therapeutics stories

• Lineage Cell Therapeutics Adds HUNT1, Projects Funding Into Q2 2028

  The company reported $45.2 million in cash, cash equivalents and marketable securities. HUNT1 is an enrolling Phase Ib/IIa program for Huntington’s disease.

  Nov 13, 2026, 1:38 AM EST · Business